Earnings Feed
Start Free
|8-KFeb 5, 5:00 PM ET

CaliberCos Inc. 8-K

Research Summary

AI-generated summary

Updated

CaliberCos Inc. Approves Charter Amendment and Equity Plan Increase

What Happened CaliberCos Inc. filed an 8-K on February 5, 2026 reporting that stockholders approved a Certificate of Amendment to increase the company’s authorized Class A Common Stock from 100,000,000 shares to 500,000,000 shares (effective 12:01 a.m. ET on January 31, 2026). At the same special meeting (January 30, 2026), stockholders also approved an amendment to the CaliberCos 2024 Equity Incentive Plan to add 1,000,000 shares immediately and to provide for annual increases equal to 15% of the Company’s outstanding Class A Common Stock on the last day of the preceding year, each January 1 from 2027 through 2034. The Company filed the Certificate of Amendment with the Delaware Secretary of State immediately following the meeting.

Key Details

  • Charter Amendment: authorized Class A Common Stock increased from 100,000,000 to 500,000,000 shares; effective 12:01 a.m. ET on Jan 31, 2026; Certificate of Amendment filed Jan 30, 2026 (Exhibit 3.1).
  • Equity Plan Amendment: adds 1,000,000 shares now and automatic annual increases of 15% of outstanding Class A shares on Jan 1 of each year from 2027–2034; Plan Amendment attached as Exhibit 10.1.
  • Plan Amendment vote tally: For 3,344,626; Against 410,655; Abstentions 7,850; Broker Non-Votes 1,685,944.
  • Adjournment vote tally (to consider other matters/establish quorum): For 4,738,465; Against 642,066; Abstentions 68,544; Broker Non-Votes 0.

Why It Matters The charter change materially increases the maximum number of Class A shares the company may issue, and the equity plan changes expand the pool available for stock-based awards. Together these actions give CaliberCos more capacity to issue shares for employee compensation, financing, acquisitions or other corporate purposes. Investors should note the larger authorized share cap and the planned annual equity-plan increases (15% formula from 2027–2034) when assessing potential dilution and tracking outstanding share counts going forward. Review the filed Certificate of Amendment and Plan Amendment (Exhibits 3.1 and 10.1) for full terms.